FindTrial
Sign In

Clinical study of rabeprazole combined with mosapride in the treatment of elder patients with chronic gastritis

Clinical study of rabeprazole combined with mosapride in the treatment of elder patients with chronic gastritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030097
Enrollment
Unknown
Registered
2020-02-23
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic gastritis

Interventions

chronic gastritis group:rabeprazole combined with mosapride
healthy control group:none

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 95 Years

Inclusion criteria

Inclusion criteria: Case group: 1. Aged >= 60 years; 2. Clinical symptoms of chronic gastritis; 3. No HP infection; 4. Diagnosis in accordance with the relevant guidelines; Control group: 1. Aged >= 60 years old; 2. No serious primary diseases of each system All sign the informed consent

Exclusion criteria

Exclusion criteria: Case group exclusion criteria 1. In the past three months, took proton pump inhibitors, vitamins, antacids, antispasmodics and analgesics, drugs for protecting gastric mucosa, H2 receptor antagonists; 2. Severe primary diseases and other tumors; 3. Drug allergy; 4. Patients with Helicobacter pylori infection.

Design outcomes

Primary

MeasureTime frame
cyclooxygenase-2, NGAL;—

Secondary

MeasureTime frame
pepsinogen;G-17;—

Countries

China

Contacts

Public ContactJing Sheng

Geriatrics Department, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

shengjing60@163.com+86 13651763192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026